Drugs / BOL-DP-o-05
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04102202 | Nov 2020 → Mar 2021 | type 1 diabetes mellitus | Breath of Life International Pharma Ltd | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BOL-DP-o-05 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04102202 ↗ |